The mechanism of insulin gene transcription control in response to glucose concentration is poorly defined. The islet-restricted transcription factors PDX1 and ISL1 interact with BETA2, activating insulin gene expression. However, their contribution and hierarchical organization in insulin expression control based on glucose concentration remain unknown. We investigated PDX1 and ISL1 regulation of insulin gene expression in pancreatic b cells cultured in normal (5 mM/L) and high (25 mM/L) glucose conditions. ISL1 interacted with BETA2 to maintain basic insulin gene transcriptional activity under normal glucose. The ISL1-recruited cofactors SET9 and JMJD3 facilitated insulin gene histone modifications under normal glucose. In high-glucose concentrations, PDX1 formed a complex with BETA2 to enhance insulin gene expression. PDX1 also recruited SET9 and JMJD3 to promote the activation of histone modulation on the insulin promoter. This is the first evidence transcription factors orchestrate epigenetic modifications to control insulin gene expression based on glucose concentration.
Introduction
Insulin is one of the critical hormones for regulating blood glucose levels and is produced exclusively by pancreatic b cells. The insulin (INS) gene was first cloned and sequenced in 1980, opening up a new field of research on the mechanisms controlling its expression (Bell et al., 1980) . To date, more than 40 regulatory transcription factors of insulin gene expression have been identified (Melloul et al., 2002; Hay and Docherty, 2006) . However, the circumstances under which these factors play their roles in regulating insulin gene transcription remain unclear.
The islet-restricted transcription factors PDX1 (pancreatic and duodenal homeobox 1), ISL1 (insulin gene enhancer binding protein, islet factor 1), and BETA2 (beta cell E-box transcription factor 2) bind to the A3/A4 and E2 boxes located between 0 and À410 bp upstream of the transcription start site in the rat insulin I promoter (RIP1) (Le Lay and Stein, 2006; Karlsson et al., 1990; Ohlsson et al., 1993) . This cis-acting regulatory sequence is essential for glucose regulation of insulin gene expression (Melloul et al., 1993) ; glucose is the central regulator of b cell function and insulin gene expression (Nielsen et al., 1985; Evans-Molina et al., 2007) .
PDX1, a master regulator of insulin gene transcription, has been implicated in glucose regulation of insulin gene transcription. PDX1 interacts with histone acetyltransferase p300 to hyperacetylate histone H4 on the insulin gene promoter in response to high glucose concentrations (Mosley et al., 2004) .
In addition to PDX1, ISL1, a LIM homeodomain protein, also binds to the A3/4 box of the insulin promoter. As a key transcription factor, ISL1 is not only involved in insulin gene regulation (Peng et al., 2005; Zhang et al., 2009) , but also in cell fate specification and embryonic development (Thor et al., 1991; Wilfinger et al., 2013) . However, whether ISL1 is involved in glucose regulation of insulin gene expression remains unclear.
Intriguingly, previous research has revealed that both PDX1 and ISL1 interact with BETA2, a bHLH transcription factor that binds to the E2 box of the insulin promoter, to activate insulin gene expression (Zhang et al., 2009; Ohneda et al., 2000) . However, no light has been shed on the detailed mechanism underlying how PDX1 and ISL1 influence insulin gene expression under different physical conditions, such as blood glucose levels. Whether the activation of insulin gene expression involves the occurrence of a similar or differing activation effect, or even a competitive effect, remains to be elucidated. In the present study, we explored the molecular mechanism underlying the function of PDX1 and ISL1 in regulating insulin gene expression in response to environmental glucose stimuli.
Recent studies have reported increasingly complicated modes of insulin gene regulation in pancreatic islet b cells, which not only involve traditional transcription regulation such as proteineprotein and proteineDNA interactions, but also epigenetic modification (Moon et al., 2014; Qiu et al., 2002; Ramalingam et al., 2014) . Gain of histone H3 trimethylated at lysine 4 (H3K4me3) and loss of H3K27me3 on the gene promoters are essential for inducing heterochromatin to euchromatin formation and gene transcription activity (Del Rizzo and Trievel, 2014; Estaras et al., 2013) . SET9 is an islet-enriched histone H3 K4especific methyltransferase that enhances PDX1 transcription activity on insulin gene regulation (Francis et al., 2005) . Our recent research has also shown that SET9 functions not only as a histone methyltransferase that increases histone H3 K4 trimethylation on the cyclin D1 promoter region, but also as an adaptor to bridge ISL1 and PDX1 in pancreatic islet b cells (Yang et al., 2015) . As a key H3K27me3 demethylase, JMJD3 plays an important role in regulating gene expression in response to environmental signaling stimuli (He et al., 2015) . We have identified a number of ISL1-or PDX1-interacting proteins by mass spectrometry in pancreatic islet b cells (Yang et al., 2015) . Among these factors, we found that SET9 and JMJD3 could be potential candidate epigenetic modifiers. Hence, we investigated whether ISL1 or PDX1 could affect insulin gene transcription in different glucose concentrations not only through traditional transcription regulation, but also in association with epigenetic modification.
In the present study, we demonstrate that ISL1 interacts with BETA2 to maintain basic insulin gene transcriptional activity in normal glucose conditions. In high-glucose conditions, PDX1 forms a complex with BETA2 to enhance insulin gene expression. As cofactors of ISL1 or PDX1, SET9 and JMJD3 facilitate insulin gene histone modification under different glucose conditions. These observations delineate a novel and precise insulin gene regulation pattern in response to glucose signals. Our study provides the first evidence that transcription factors orchestrate epigenetic modifications for proper control of insulin gene expression in response to environmental signaling stimuli.
Materials and methods

Diabetes animal model and rat pancreatic islet isolation
The animal experiments were performed in accordance with the ethical principles and guidelines for scientific experiments on animals of the Swiss Academy of Medical Sciences (1995) . The Animal Care and Use Committee of Peking University approved all protocols (LA 2010-066) .
Db/db mice (14e16 weeks old), which are homozygous for the db gene and exhibit an obese and diabetic phenotype, were used for the type 2 diabetes animal model. Db/m mice, which are heterozygous for the db gene and exhibit a non-diabetic, normal phenotype, were used as controls to the db/db mice. The mice were anesthetized with 5 mg/100 g body weight sodium pentobarbital, and the pancreatic tissues were removed. RNA was prepared from these tissues and used for real-time reverse transcription (RT)-PCR assay.
Rat pancreatic islets were isolated from 100 to 120 g male SpragueeDawley rats as previously described (Guo et al., 2011) . Briefly, donor pancreases were perfused in situ with collagenase V (3 mg/mL; SigmaeAldrich, St. Louis, MO, USA), harvested immediately thereafter, and incubated at 37 C with gentle vortexing (375 rpm) for 30 min. Islets were released from the pancreas and were isolated by hand. The isolated pancreatic islets were washed with Hank's solution twice at 4 C, counted, and cultured in RPMI 1640 complete medium with 25 or 5 mmol/L glucose for 24 h or for an indicated duration.
Cell culture
Monolayer cultures of the hamster pancreatic islet b cell line HIT-T15 (ATCC number CRL-1777, Manassas, Virginia, USA) and mouse insulinoma cell line NIT-1 (ATCC number CRL-2055) were maintained in RPMI 1640 (GIBCO BRL, New York, USA) complete medium, which contained 11.1 mmol/L glucose with 2 mM/L glutamine, 100 U/mL penicillin, 100 U/mL streptomycin, and 10% fetal bovine serum. The medium was changed every 1e2 days until the cells were transferred to medium containing 25 or 5 mmol/L glucose and cultured for a further 24 h or for an indicated duration, and were harvested for the remaining experiments.
Insulin secretion assay
Rat pancreatic islets (200 islets/well in 6-well plates) or HIT-T15 cells (5 Â 10 4 /well in 6-well plates) were cultured in RPMI 1640 medium with 11.1 mmol/L glucose for 24 h. Cells were washed in glucose-free KrebseRinger bicarbonate buffer three times and reincubated in RPMI 1640 medium containing 5 or 25 mmol/L glucose at 37 C for 60 min. The medium was collected after gentle centrifugation and stored at À20 C for measurement of insulin secretion using a radioimmunoassay (RIA) kit (China Atomic Energy Diagnostics, Beijing, China). Data were normalized to total protein.
Quantitative real-time RT-PCR and RNA interference (RNAi)
Total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. Amplifications were performed in an ABI 7300 Real-Time PCR System (Applied Biosystems Co, Carlsbad, CA, USA) with different primers (Table 1 ). All annealing temperatures were 60 C. Transcript levels were normalized to 18S RNA. Each value represents the average of at least three independent experiments. RNAi duplexes for Pdx1 (si-PDX1), Isl1 (si-ISL1), or control siRNA (non-silencing, Non) were obtained from GeneChem (Shanghai, China) ( Table 2 ) and used to transfect HIT-T15 cells according to the manufacturer's instructions.
Plasmid constructs and luciferase assays
The plasmid constructs pRIP1-luc (luciferase reporter plasmid containing a 0 to À410-bp sequence upstream from the transcription start site in RIP1), pcDNA3-ISL1, pcDNA3-PDX1, and pCMV-BETA2 have been previously described (Zhang et al., 2014; Lu et al., 2005) . Cells were seeded and cultured in a 24-well plate Table 1 Real-time RT-PCR primer sequences.
Genes
Primer sequences (5
and transfected with the appropriate plasmid DNA using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions when they were 80% confluent. The total amount of DNA was kept constant using a pcDNA3 plasmid. Cells were cultured in RPMI 1640 medium with 11.1 mmol/L glucose. After 24-h transfection, cells were changed to medium containing 5 or 25 mmol/L glucose and the luciferase activity was assayed 12 h later. Luciferase activity was normalized to Renilla luciferase activity. All experiments were performed in triplicate, and three independent repeat experiments were performed.
Chromatin immunoprecipitation (ChIP) and ChIP re-IP assays
ChIP and ChIP re-IP experiments were performed in HIT-T15 cells according to previously described methods (Yang et al., 2015) . After elution, real-time PCR or conventional PCR were performed to amplify the DNA fragment containing the insulin promoter covering the ISL1/BETA2 or PDX1/BETA2 binding sites with the following primers, F: 5 0 -CCAATGAGTGCTTTCTGC-3 0 , R: 5 0 -AAGTACCTCCTCTCTGCC-3 0 (144-bp fragment).
Immunoprecipitation and western blot analysis
Cell lysates were prepared using radioimmunoprecipitation assay lysis buffer (P0013E; Beyotime, Shanghai, China) containing protease inhibitor cocktail (469313200; Roche, Basel, Switzerland) according to the manufacturer's instructions. Immunoprecipitation and western blotting were carried out as described previously using the antibodies listed below (Zhang et al., 2014) . For semiquantitative assay, the post-immunoprecipitation supernatant was subjected to western blotting using antielamin B antibody as Table 2 RNAi duplex sequences.
Genes
RNAi duplex sequences (5
Sense, GAGACAUGGUGGUUUAtt Antisense, UUUCUCCUUGCACCUCtt Non-silencer siRNA Sense, UUCUCCGAACGUGUCACGUtt Antisense, ACGUGACACGUUCGGAGAAtt an internal control. The antibodies used in these experiments were rabbit monoclonal anti-ISL1 (ab3727-1; Abcam, Cambridge, UK.), mouse monoclonal anti-BETA2 (sc-1084; Santa Cruz, Dallas, Texas, USA.), rabbit polyclonal anti-PDX1 (ab47267; Abcam), mouse monoclonal anti-SET7/9 (A301-747A; Bethyl, Montgomery, Texas, USA), mouse monoclonal anti-JMJD3 (sc-130157; Santa Cruz), antiH3K4me1 (ab8895; Abcam), anti-H3K4me3 (17-678; Millipore), anti-H3K27me3 (ab6002; Abcam), mouse monoclonal antieb-actin (sc-130300; Santa Cruz), and antielamin B (sc-374015, Santa Cruz).
Statistical analysis
Data are expressed as the mean ± standard deviation (SD). Comparisons between groups were analyzed using Student's t-test or analysis of variance (ANOVA), and the StudenteNewmaneKleuss method was used to estimate the level of significance. Differences were considered statistically significant at p < 0.05.
Results
3.1. Insulin (Ins), Pdx1, Isl1, and Beta2 gene expression patterns in diabetic mice pancreatic islets and in pancreatic cells cultured in normal or high-glucose medium differed
To establish the Ins, Pdx1, Isl1, and Beta2 gene expression patterns under different glucose conditions, pancreatic islets were isolated from hyperglycemic type 2 diabetes db/db mice (14e16 weeks, blood glucose, 26.7 ± 3.5 mmol/L) and normoglycemic db/m mice (blood glucose, 5.6 ± 1.2 mmol/L). In addition, NIT-1 and HIT-T15 b cells were cultured in RPMI 1640 medium containing high glucose concentrations (25 mmol/L) or normal glucose concentrations (5 mmol/L) for 12 h. Pdx1 and Ins expression was increased significantly in high-glucose conditions as compared with normal glucose conditions; Isl1 and Beta2 expression was essentially unchanged under both high-or normal glucose conditions (Fig. 1AeE , p < 0.01). Consistently, insulin secretion from the cultured primary rat pancreatic islets and the NIT-1 and HIT-T15 cells responded positively to high-glucose conditions (Fig. 1F , p < 0.01). The results imply that PDX1, ISL1, and BETA2 may play different roles in insulin gene expression in response to glucose signaling.
3.2. PDX1 and ISL1 synergistic effects with BETA2 on the insulin promoter differed with the glucose concentration in culture
We demonstrated differing Pdx1 and Isl1 gene expression patterns in b cells cultured with high or normal glucose concentrations. To investigate whether they play different regulatory roles on insulin gene expression in response to glucose signaling, a luciferase reporter plasmid containing RIP1 (0 to À410 bp) was transfected into NIT-1 or HIT-T15 cells together with pcDNA3-PDX1 or pcDNA3-ISL1 alone or co-transfected with pCMV-BETA2, respectively. As shown in Fig. 2A and C, PDX1 alone or with BETA2 exhibited higher activity on the insulin gene promoter in highglucose cultures as compared to those containing 5 mmol/L glucose. In contrast, the activity of ISL1 alone and with BETA2 remained similar on the insulin gene promoter in high-or normal glucose cultures ( Fig. 2B and D) . A luciferase reporter plasmid with the firefly luciferase gene inserted downstream of the rat insulin I mini-enhancer (À247~À197 bp, containing E2 and A3/A4-boxes) also was used to test the transcription activities of PDX1, ISL1 and BETA2 (Zhang et al., 2009 ). Similar to RIP1 promoter, PDX1 and ISL1 synergistic effects with BETA2 differed with the glucose concentrations in culture were also observed on the mini-enhancer (data not shown). Intriguingly, when the plasmid of PDX1 was cotransfected with ISL1, ISL1 showed a competitive effect with PDX1 and weaken PDX1 on transactivation of insulin promoter with high glucose culture (Fig. S1 ). We suppose that it is probably because ISL1 owns weaker transactivation ability of ISL1 on the insulin promoter is weaker than that of PDX1 with 25 mM glucose culture (Fig. S1 ), but both PDX1 and ISL1 recognize the same elements (A3/A4 box) and may competitively bind on the insulin promoter (Zhang et al., 2009) .
It should be mentioned that the transactivation of insulin promoter by PDX1 is increased only in 25 mM glucose medium not in 5 mM glucose medium although the total protein levels were not significantly differed in the cells cultured with 25 mmol/L glucose condition or with 5 mmol/L glucose condition (Fig. S2A) . However, PDX1 protein was increased significantly in nuclear extracts from the cells cultured in high-glucose conditions as compared with normal glucose conditions (p < 0.01, Fig. S2B ). ISL1 and BETA2 expression was essentially unchanged under either high or normal glucose conditions. As a gene promoter could be activated effectively by activators in nuclei, only nuclear PDX1 protein could increase insulin gene transcription significantly. Furthermore, Isl1 knockdown (si-Isl1) in HIT-T15 cells cultured with normal glucose medium attenuated insulin secretion significantly, while Pdx1 knockdown (si-Pdx1) did not affect insulin secretion in cells cultured in normal glucose medium (Fig. 2E , p < 0.01). In contrast, the knockdown of Pdx1, but not Isl1, attenuated insulin secretion significantly in cells cultured with high-glucose medium (Fig. 2E , p < 0.01). Pdx1 and Isl1 did not exert synergistic effects under normal or high glucose conditions. In addition, the inhibitory effect on insulin gene expression following Pdx1 knockdown remained until 48 h after cells had been transferred to high-glucose medium, while insulin gene expression still peaked at 24 h following Isl1 knockdown (Fig. 2F) . These results indicate that PDX1 may serve as the main activator of insulin gene expression in b cells cultured in high-glucose medium, while ISL1 may mainly maintain basic insulin gene expression under normal glucose conditions.
PDX1 and ISL1 interacted differently with BETA2 according to the glucose concentration in culture
We and others have previously reported that both PDX1 and ISL1 activate insulin promoter synergistically with BETA2 in b cells (Zhang et al., 2009 ,Ohneda et al., 2000 . However, the relationship between PDX1eBETA2 and ISL1eBETA2 remains unclear. To investigate why PDX1 and ISL1 regulate insulin gene expression differently in high-or normal glucose conditions, Co-IP was performed to analyze whether PDX1eBETA2 or ISL1eBETA2 could form different complexes in response to different glucose signals. PDX1 interacted with BETA2 in HIT-T15 cells cultured in highglucose medium but no PDX1eBETA2 complex was formed when the cells were cultured in normal glucose medium. Conversely, the ISL1eBETA2 complex was observed only in cells cultured in normal glucose medium (Fig. 3A and B) . Taken together, our data show that PDX1, rather than ISL1, associates with BETA2 to form a PDX1eBETA2 complex in response to high glucose signals. In normal glucose conditions, the ISL1eBETA2 complex is formed to maintain the basic level of insulin gene expression.
PDX1 and ISL1 DNA binding ability to the RIP1 differed according to the glucose concentration in culture
To confirm whether the PDX1eBETA2 or ISL1eBETA2 complex binds to the insulin promoter region under high-or normal glucose conditions, ChIP assay was performed in HIT-T15 cells cultured in 5 or 25 mmol/L glucose medium. PDX1eBETA2 formed a transcriptional activation complex with the insulin promoter following 25 mmol/L glucose culture but not 5 mmol/L glucose culture (Fig. 4A, B and D) . The ISL1eBETA2 complex was only identified in cells cultured in normal glucose conditions (Fig. 4AeC) . Hence, we suspect that ISL1 interacts with BETA2 to maintain basic insulin gene expression under normal glucose conditions. When the cells are challenged with high glucose, PDX1 forms a complex with BETA2 to promote insulin gene expression.
PDX1 and ISL1 histone modification regulatory effects on the insulin promoter differed according to the glucose concentration in culture
Previous studies have demonstrated that histone modifications are involved in regulating the expression of some genes in pancreatic islet b cells (Fujimaki et al., 2015; Ogihara et al., 2009) . To investigate whether the epigenetic mechanism is also involved in insulin gene regulation in response to glucose signaling, ChIP assays were performed to detect several histone modifications. Any modification, whether classic "active", e.g., H3K4me1 and H3K4me3, or "repressive", e.g., H3K27me3, at the PDX1/ISL1-binding region on the insulin promoter effected no change in HIT-T15 cells cultured in normal or high-glucose medium (Fig. 5A) . Meanwhile, there was a strikingly high level of H3K4me1 and H3K4me3 modification as compared with the very low level of H3K27me3 on the insulin promoter (Fig. 5A) . The results are consistent with the insulin gene being in active transcription state in pancreatic islet b cells. However, following Isl1 knockdown, these "active" histone modifications were markedly decreased in HIT-T15 cells cultured in normal glucose medium but not in cells cultured in high-glucose medium, while H3K27me3 modification at the PDX/ISL1-binding region of the insulin promoter was increased (Fig. 5BeD) . Pdx1 knockdown had the opposite effect on H3K4me1, H3K4me3, and H3K27me3 modifications to that of Isl1 knockdown (Fig. 5EeG) . The above changes in histone modification are consistent with the change in insulin secretion levels in the cells with Isl1 or Pdx1 knockdown in response to different glucose concentrations (Fig. 2E) . Therefore, we surmise that PDX1 or ISL1 can alter the status of histone H3K4 and H3K27 methylation on the insulin promoter in b cells according to the glucose concentration in culture.
3.6. PDX1 and ISL1 recruitment of SET9 and JMJD3 on the insulin promoter differed according to the glucose concentration in culture We explored how PDX1 or ISL1 alter the status of histone H3K4 and H3K27 methylation on the insulin promoter according to the glucose concentration in culture. Previously, we had screened ISL1-or PDX1-interacting proteins by mass spectrometry in pancreatic islet b cells and identified SET9 and JMJD3 as potential candidates (Yang et al., 2015) . SET9 is a histone H3K4especific methyltransferase and a novel enzymatic cofactor necessary for maintaining pancreatic islet gene transcription (Ogihara et al., 2009 ). JMJD3, a H3K27 demethylase that acts as a critical epigenetic regulator, is involved in the development, differentiation, and maintenance of cell fate; tumorigenesis; and neurogenesis (He et al., 2015; Ene et al., 2012; Iida et al., 2014; Park et al., 2014; Yan et al., 2014) . As we had previously identified the ISL1-or PDX1-interacting proteins by mass spectrometry in pancreatic islet b cells (Yang et al., 2015) , we suspected that ISL1 or PDX1 may affect insulin gene transcription through epigenetic modification, which may be associated with the two enzymatic cofactors above. Consequently, to test this hypothesis, Co-IP and ChIP re-IP were performed to determine whether ISL1 or PDX1 could form a complex with SET9 or JMJD3 to bind directly to the insulin promoter according to the glucose concentration in culture. In cells cultured in normal glucose medium, ISL1 interacted with SET9 or JMJD3, but did so sparsely in cells cultured in high-glucose medium (Fig. 6A and C). Conversely, PDX1eSET9 or PDX1eJMJD3 interaction was observed in cells cultured in high-glucose medium rather than normal glucose medium ( Fig. 6B and D) . Hence, these results show that both ISL1 and PDX1 can recruit SET9 or JMJD3, but under different glucose conditions. Furthermore, ChIP and ChIP re-IP confirmed that ISL1eSET9 or ISL1eJMJD3 occupied and colocalized on the insulin promoter only in cells cultured in normal glucose medium (Fig. 6E and G) . In contrast, PDX1eSET9 or PDX1eJMJD3 was enriched on the insulin promoter only in HIT-T15 cells cultured in high-glucose medium ( Fig. 6F and H) .
Taken together, the results indicate that ISL1 or PDX1 can regulate insulin gene expression both at traditional transcription level and at epigenetic level. ISL1 and PDX1 play different roles based on differing glucose conditions.
Discussion
Glucose is the major physiological regulator of insulin gene expression (Poitout et al., 2006) . Some glucose-responsive transcription control elements on the insulin gene have been identified, and several transcription factors have been implicated as being responsible for them (Pino et al., 2005) . However, how glucose coordinately controls the recruitment of transcription factors, e.g., PDX1 and ISL1, to bind the insulin promoter and govern insulin gene expression remains puzzling.
Previously, we discovered that ISL1 regulates insulin gene expression by interacting with BETA2 (Zhang et al., 2009 ). However, accumulating evidence has enhanced the conclusion that PDX1, rather than ISL1, exerts greater insulin gene regulation (Le Lay and Qiu et al., 2002; Iguchi et al., 2005) . Intriguingly, both PDX1 and ISL1 can bind to the A3/A4 box in the insulin promoter, which is one of the major glucose-responsive transcription control elements for insulin gene expression. Hence, why both activators are required to bind the same site to regulate insulin gene expression is thought provoking. Is the relationship between them competitive or compatible?
To clarify this, we first determined the Pdx1 and Isl1 gene expression patterns in islet b cells cultured in different glucose concentrations. High-glucose culture promoted Pdx1 gene expression, which is similar to the reports of others (Iguchi et al., 2005) . In contrast with Pdx1, Isl1 and Beta2 expression was barely affected by glucose, which implies the presence of differing regulatory effects on insulin gene expression in normal or high-glucose conditions. Further research has provided evidence supporting our speculation. PDX1 alone or with BETA2 had higher activation efficiency on the insulin gene promoter following stimulation with high glucose levels. Compared with PDX1, ISL1 contributed more greatly to insulin promoter activation in normal glucose conditions. Although these results indicate that PDX1 plays a major role in glucose regulation of insulin gene transcription, ISL1 is not dispensable. Only combined expression of PDX1 and ISL1, rather than PDX1 alone, induces insulin production in immature enterocytes (Kojima et al., 2002) . In the present study, we also found that if only the Isl1 gene was knocked down, not only was insulin secretion decreased in the cells cultured in normal glucose, the initiation of insulin gene expression was also delayed (Fig. 2E and  F) . Collectively, the results suggest that PDX1 might potentiate insulin gene expression in response to high-glucose stimulation, while the role of ISL1 to maintain the basic level of insulin gene transcription. Our hypothesis on the diverse roles in PDX1-or ISL1-mediated insulin gene expression regulation is supported by the reports of others. The absence of Pdx1 in pancreatic islets can cause defects in glucose-stimulated insulin gene transcription in Psammomys obesus, a rodent model of type 2 diabetes, whereas a number of other insulin gene regulators, including MafA (v-maf musculoaponeurotic fibrosarcoma oncogene homolog A), do not affect glucose-stimulated insulin gene transcription (Leibowitz et al., 2001 ). The NES2Y cell line, isolated from patient pancreatic islets, lacks PDX1. Although the cells can express the insulin gene, they cannot upregulate insulin gene transcription in response to high glucose levels (MacFarlane et al., 1999) . These reports provide evidence that PDX1 can act as a potent glucose-responsive transcriptional activator in insulin gene expression. Regarding ISL1, low insulin levels have been detected in a number of extrapancreatic tissues, including the brain, thymus, lachrymal glands, and salivary glands, while ISL1 instead of PDX1 is involved in regulating insulin expression in these organs (Kojima et al., 2004) . Brain tumor cells producing low levels of insulin can express ISL1 without expressing PDX1 (Nakamura et al., 2001) . Consistently, the insulin gene expression detected in these tissues or tumors is not responsive to glucose stimulation. These studies imply that ISL1 can activate insulin gene expression at a basic level, but is not a glucoseresponsive transcriptional activator.
Moreover, we explored the mechanism responsible for PDX1 and ISL1 differential regulation of insulin gene expression in normal or high-glucose conditions. Although BETA2 interacts with PDX1 and ISL1, there may be a competitive relationship between the two resultant complexes, i.e., PDX1eBETA2 and ISL1eBETA2. PDX1 can recruit BETA2 to form a complex, binding the insulin promoter in high-glucose conditions, while the ISL1eBETA2 complex on the insulin promoter is present only in normal glucose medium culture. Why does PDX1 interact with BETA2 only in higher than normal glucose exposure? We found that 25 mmol/L glucose cultures could enrich PDX1 in nuclei more significantly than that with 5 mmol/L glucose culture. Enriched PDX1 exhibited a stronger recruitment with BETA2. Why is PDX1 enriched in b cells nuclear in higher than normal glucose exposure? The posttranslational regulation of PDX1 might be one reason for this. In b cells incubated in low-glucose conditions, PDX1 is localized to the cytoplasm; in high-glucose conditions, PDX1 is localized to the nucleus (Welker et al., 2013) . Glucose signals promote phosphorylation and translocation of PDX1 to nuclei (Meng et al., 2010) . However, different from the high glucose-induced nuclear translocation of PDX1, ISL1 exhibited constant nuclear localization in cells cultured in either normal or high glucose. Additionally, mass spectrometry did not detect phosphorylated modification of ISL1 in pancreatic islet b cells cultured in different glucose concentrations (data not shown).
Hence, we speculated that high glucose can promote the modification and nuclear translocation of PDX1 and that enriched PDX1 is a stronger BETA2 recruiter than ISL1 on the insulin promoter to potentiate insulin gene transcription. When b cells are cultured in normal glucose, PDX1 is dephosphorylated by phosphatase and translocates to the cytoplasm, losing the ability to interact with BETA2. ISL1 is localized to the nucleus, and accordingly has the chance to recruit BETA2 to the insulin promoter.
The regulation of insulin gene expression is a complicated network involving more than 40 nuclear factors. Besides PDX1, ISL1
and BETA2, there are other b cell-restricted factors in response to glucose on insulin gene transcription. MafA, binding to the C1 box in the insulin promoter, also plays a critical role in b cell-specific insulin gene transcription as well as in glucose-regulated expression and secretion (Aguayo-Mazzucato et al., 2011; Nishimura et al., 2015; Zhang et al., 2005) . The relationships among these activators involved in glucose-responsive insulin expression remain to be elucidated.
Both SET9 and JMJD3 are involved in gene activation by inhibiting heterochromatin formation (Estaras et al., 2013; Fujimaki et al., 2015) . The insulin gene is expressed almost exclusively in b cells of the pancreatic islets of Langerhans. One major feature of the insulin gene is in the b cell euchromatin structure. How can the insulin gene maintain an active chromatin state? It has been reported that the proximal insulin promoter is hyperacetylated at histone H3 and hypermethylated at H3K4 only in b cells. This hyperacetylation is caused by histone acetyltransferase p300 that is recruited by PDX1 to the proximal promoter, and the hypermethylation at the H3K4 modification correlates with the SET9 that is also recruited by PDX1 to the promoter (Mosley et al., 2004; Francis et al., 2005) . However, to our knowledge, whether H3K27me3 and its modulation enzyme, i.e., JMJD3, are involved in the euchromatic structure around the insulin gene has not been reported. In our study, we demonstrated that PDX1 recruits not only SET9 but also JMJD3 on the insulin gene promoter to maintain the H3K4me1, H3K4me3, and de-H3K27me3 state of the insulin gene in b cells challenged with high glucose levels. These studies suggest that PDX1 plays a crucial role in maintaining the euchromatic structure of the insulin gene. However, in normal glucose conditions, PDX1 is located in the cytoplasm, and cannot recruit the chromatin modulation enzymes in the nucleus. How the active structure of the insulin gene is maintained remains poorly defined. Here, we observed that ISL1 instead of PDX1 interacted with SET9 and JMJD3 to bind the insulin promoter to maintain the H3K4me1, H3K4me3, and de-H3K27me3 state. Therefore, we propose a model in which a unique combination of transcription factors facilitates insulin gene transcription in b cells, namely, by PDX1 in highglucose conditions and by ISL1 in normal glucose conditions, which acts in the setting of an open, euchromatic structure of the insulin gene.
Taken together, our findings reveal a novel and precise mechanism of PDX1 and ISL1 systematic regulation of insulin gene expression at both traditional transcription level and at epigenetic level. ISL1 and PDX1 play different roles in response to varying glucose concentrations.
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